Literature DB >> 8368329

Pulmonary surfactant protein A-mediated uptake of phosphatidylcholine by alveolar type II cells.

A Tsuzuki1, Y Kuroki, T Akino.   

Abstract

Pulmonary surfactant protein A (SP-A)-mediated uptake of phosphatidylcholine (PC) by alveolar type II cells was investigated. SP-A enhanced the uptake of liposomes containing dipalmitoylphosphatidylcholine (DPPC), 1-palmitoyl-2-linoleoyl phosphatidylcholine (PLPC), or 1,2-dihexadecyl-sn-glycero-3-phosphocholine (DPPC-ether), a diether analogue of DPPC, but about twice as much DPPC was taken up by type II cells as PLPC or DPPC-ether. When subcellular distribution was analyzed, 51.3 +/- 2.9% (mean +/- SD, n = 3) of cell-associated radiolabeled DPPC was recovered in the lamellar body-rich fraction in the presence of SP-A, whereas only 19.3 +/- 1.9% (mean +/- SD, n = 3) was found to this fraction in the absence of SP-A. When type II cells were incubated either with DPPC at 0 degree C or with DPPC-ether at 37 degrees C, or no cells were included, low proportions of the cell-associated lipids were present in the fractions corresponding to lamellar bodies even in the presence of SP-A. Anti-SP-A antibody significantly reduced the radioactivity incorporated into the lamellar body fraction. Phosphatidylcholine that had been incorporated into lamellar bodies remained largely intact when SP-A was present. Subcellular fractionations of type II cells with radiolabeled SP-A and DPPC revealed that the sedimentation characteristics of cell-associated SP-A are different from those of DPPC, although a small broad peak of radiolabeled SP-A was found in the lamellar body fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8368329     DOI: 10.1152/ajplung.1993.265.2.L193

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Binding of adenovirus capsid to dipalmitoyl phosphatidylcholine provides a novel pathway for virus entry.

Authors:  Larissa Balakireva; Guy Schoehn; Eric Thouvenin; Jadwiga Chroboczek
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.

Authors:  O Poulain-Godefroy; N Mielcarek; N Ivanoff; F Remoué; A M Schacht; N Phillips; C Locht; A Capron; G Riveau
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 3.  Rab38 Mutation and the Lung Phenotype.

Authors:  Kazuhiro Osanai
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

Review 4.  Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis.

Authors:  Takayuki Takimoto; Yukihiro Nakamura
Journal:  Diseases       Date:  2022-06-27

5.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

6.  Transient in utero disruption of cystic fibrosis transmembrane conductance regulator causes phenotypic changes in alveolar type II cells in adult rats.

Authors:  Ashraf Gad; Delon L Callender; Erin Killeen; Joseph Hudak; Malgosia A Dlugosz; Janet E Larson; J Craig Cohen; Avinash Chander
Journal:  BMC Cell Biol       Date:  2009-03-31       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.